Literature DB >> 11328706

Neuroblastoma cell lines--a versatile in vitro model in neurobiology.

P Shastry1, A Basu, M S Rajadhyaksha.   

Abstract

Neuroblastoma (NB) cell lines are transformed, neural crest derived cells, capable of unlimited proliferation in vitro. These cell lines retain the ability of differentiation into neuronal cell types on treatment with various agents. This ability of NB cells to proliferate as well as to differentiate makes it an excellent in vitro system for various studies. This review article focuses on the applications and potential uses of murine and human NB cell lines. NB cells are extensively used for testing neurotoxicity of putative drugs such as antimalarial or anticancer agents. NB cell lines have wide applications in virus research to understand various aspects of virus-host cell interactions at the molecular and cellular levels. They have been used to dissect the relationships between proliferation, differentiation and apoptosis. This feature has been useful in understanding the pediatric cancer--neuroblastoma and for development of newer therapies.

Entities:  

Mesh:

Year:  2001        PMID: 11328706     DOI: 10.3109/00207450108986509

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  14 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Molecular morphology of neuronal apoptosis: analysis of caspase 3 activation during postnatal development of mouse cerebellar cortex.

Authors:  Laura Lossi; Ilaria Tamagno; Adalberto Merighi
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

3.  Cytotoxic effect of p-Coumaric acid on neuroblastoma, N2a cell via generation of reactive oxygen species leading to dysfunction of mitochondria inducing apoptosis and autophagy.

Authors:  S Shailasree; M Venkataramana; S R Niranjana; H S Prakash
Journal:  Mol Neurobiol       Date:  2014-04-24       Impact factor: 5.590

4.  Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction.

Authors:  Stefano Doccini; Federica Morani; Claudia Nesti; Francesco Pezzini; Giulio Calza; Rabah Soliymani; Giovanni Signore; Silvia Rocchiccioli; Katja M Kanninen; Mikko T Huuskonen; Marc H Baumann; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cell Death Discov       Date:  2020-03-30

5.  Dorsal root ganglion neurons carrying a P301S Tau mutation: a valid in vitro model for screening drugs against tauopathies?

Authors:  Niels Alberts; Karlijn Groen; Lisette Klein; Marek J Konieczny; Mandy Koopman
Journal:  J Neurosci       Date:  2014-04-02       Impact factor: 6.167

6.  Growth hormone production and action in N1E-115 neuroblastoma cells.

Authors:  Chelsey Grimbly; Brent Martin; Edward Karpinski; Steve Harvey
Journal:  J Mol Neurosci       Date:  2009-03-20       Impact factor: 3.444

7.  GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.

Authors:  Amy Dickey; Stephen Schleicher; Kathleen Leahy; Rong Hu; Dennis Hallahan; Dinesh Kumar Thotala
Journal:  J Neurooncol       Date:  2010-12-16       Impact factor: 4.130

8.  Internalization and axonal transport of the HIV glycoprotein gp120.

Authors:  Sarah Berth; Hector Hugo Caicedo; Tulika Sarma; Gerardo Morfini; Scott T Brady
Journal:  ASN Neuro       Date:  2015-01-30       Impact factor: 4.146

9.  HIV Glycoprotein Gp120 Impairs Fast Axonal Transport by Activating Tak1 Signaling Pathways.

Authors:  Sarah H Berth; Nichole Mesnard-Hoaglin; Bin Wang; Hajwa Kim; Yuyu Song; Maria Sapar; Gerardo Morfini; Scott T Brady
Journal:  ASN Neuro       Date:  2016-11-20       Impact factor: 4.146

10.  Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.

Authors:  Sandra Coecke; Alan M Goldberg; Sandra Allen; Leonora Buzanska; Gemma Calamandrei; Kevin Crofton; Lars Hareng; Thomas Hartung; Holger Knaut; Paul Honegger; Miriam Jacobs; Pamela Lein; Abby Li; William Mundy; David Owen; Steffen Schneider; Ellen Silbergeld; Torsten Reum; Tomas Trnovec; Florianne Monnet-Tschudi; Anna Bal-Price
Journal:  Environ Health Perspect       Date:  2007-02-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.